// App-Quantinova.ai

: Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function

Researchers

Presenter

  • Jorge F. Maspero

Principal Investigators

  • David M.G. Halpin

  • David Jackson

  • Nicola A. Hanania

  • Mario Castro

  • Christian Domingo

  • Nadia Daizadeh

  • Michel Djandji

  • Paul Rowe

  • Yamo Deniz

Medical Centers

  • Fundacion GADOR, Buenos Aires, Argentina

  • University of Exeter , Medical School, Exeter, United Kingdom

  • Guy’s Severe Asthma Centre, King’s College London, London, United Kingdom

  • Baylor College of Medicine, Houston, Texas, United States

  • University of Utah School of Medicine, Salt Lake City, United States of America

  • Corporació Sanitaria Parc Taulí, Sabadell, Barcelona, Spain

  • Sanofi US, Bridgewater, United States of America

  • Regeneron Pharmaceuticals - Tarrytown - United States of America

Locations

  • Argentina

  • United Kingdom

  • United States

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • Dupilumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • NCT02528214

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved